+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison between F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature



Comparison between F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature



Radiology Research and Practice 2011: 912504



Aim. to compare (18)F-Fluorodeoxyglucose positron emission tomography (FDG-PET) to sentinel lymph node biopsy (SLNB) for regional lymph nodal staging in patients with melanoma. Methods. We performed a literature review discussing original articles which compared FDG-PET to SLNB for regional lymph nodal staging in patients with melanoma. Results and Conclusions. There is consensus in the literature that FDG-PET cannot replace SLNB for regional lymph nodal staging in patients with melanoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052223609

Download citation: RISBibTeXText

PMID: 22242204

DOI: 10.1155/2011/912504


Related references

Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. European Journal of Surgical Oncology 29(8): 662-664, 2003

Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. Journal of Clinical Oncology 17(5): 1508-1515, 1999

Regional lymph node assessment for conjunctival melanoma: sentinel lymph node biopsy and positron emission tomography. British Journal of Ophthalmology 92(4): 443-445, 2008

Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node. British Journal of Dermatology 164(6): 1235-1240, 2011

Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy. Journal of the European Academy of Dermatology and Venereology 22(1): 126-127, 2008

Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients. Dermatologic Surgery 29(3): 245-248, 2003

A prospective study evaluating 18 F-Fluorodeoxyglucose ( 18 FDG) positron emission tomography (PET) in the assessment of axillary nodal spread in women undergoing sentinel lymph node biopsy (SLNB) for breast cancer. Journal of Clinical Oncology 26(15_Suppl): 533-533, 2016

Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study. Medicine 97(16): E0410, 2018

A prospective comparison of positron emission tomography scanning, sentinel lymph node biopsy and axillary dissection in staging patients with early stage breast cancer. Breast Cancer Research & Treatment 76(Suppl. 1): S129, 2002

The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study. Medicine 97(38): E12522, 2018

Sentinel lymph node excision (SLNE) and positron emission tomography in the staging of stage I-II melanoma patients. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 54(5): 440-447, 2003

DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark. Bju International 118(1): 102-111, 2016

Lack of clinical impact of 18 F-fluorodeoxyglucose positron emission tomography with simultaneous computed tomography for stage I and II Merkel cell carcinoma with concurrent sentinel lymph node biopsy staging: A single institutional experience from Westmead Hospital, Sydney. Australasian Journal of Dermatology 58(2): 99, 2017

Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Breast Journal 10(2): 89-93, 2004

Role of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy. Indian Journal of Nuclear Medicine 28(3): 138-143, 2013